Exclusive: ACR Convergence 2024 | Focus Rheums

Articles tagged with "Kaufman"

Biosimilar for Infliximab Launched in Europe

Michele B. Kaufman, PharmD, BCGP | April 1, 2015

Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP | March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Drug Interactions for Trimethoprim/ Sulfamethoxazole Come to Light

Michele B. Kaufman, PharmD, BCGP | February 1, 2015

Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information

2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News

Michele B. Kaufman, PharmD, BCGP | January 1, 2015

Plus, hydrocodone combination products and brodalumab

Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals

Michele B. Kaufman, PharmD, BCGP | December 1, 2014

Plus, rheumatology drug news, safety updates

Atypical Fractures Associated with Bisphosphonates

Michele B. Kaufman, PharmD, BCGP | November 1, 2014

Plus, FX006, odanacatib and other rheumatology drug news, safety updates

Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals

Michele B. Kaufman, PharmD, BCGP | October 1, 2014

Plus, rheumatology drug news, safety updates

Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | September 1, 2014

Plus, rheumatology drug news, safety updates

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP | August 1, 2014

Plus, rheumatology drug news from EULAR 2014